Who Paid My Doc
1L Biliary Tract Cancer
Research payments
$1,122,151
Through program year 2025, $1,122,151 in research payments was reported against 1L Biliary Tract Cancer, across 92 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,891 | 2 |
| 2024 | Research | $47,468 | 10 |
| 2023 | Research | $61,259 | 5 |
| 2022 | Research | $347,884 | 33 |
| 2021 | Research | $662,650 | 42 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Spigel Nashville, TN Named on 28 payments
- Michael Castine Baton Rouge, LA Named on 13 payments
- Daneng Li Duarte, CA Named on 11 payments
- Tri Le Gardena, CA Named on 10 payments
- Joseph Franses Boston, MA Named on 8 payments
- John Strickler Seattle, WA Named on 4 payments
- Jingquan Jia Durham, NC Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.